Activation of p53 as a causal step for atherosclerosis induced by polycyclic aromatic hydrocarbons

Area of Science:

• Molecular Biology
• Toxicology
• Cellular Signaling

Background:

• Polycyclic Aromatic Hydrocarbons (PAHs) are environmental pollutants.
• Liver X Receptors (LXRs) regulate lipid metabolism and gene expression.
• p53 is a tumor suppressor protein involved in DNA damage response.

Purpose of the Study:

• To investigate if PAH metabolites activate p53 through DNA damage.
• To determine if activated p53 suppresses Liver X Receptor (LXR)-mediated signaling.
• To elucidate a direct mechanism linking PAH exposure to disrupted LXR function.

Main Methods:

• Utilized HepG2 (wild-type p53) and Hep3B (mutant p53) cell lines.
• Administered 3-methylchoranthrene (MC) and doxorubicin (Dox) as PAH exposure models.
• Assessed LXR-mediated trans-activation, p53 activity, and gene/protein expression (ATP binding cassette A1, retinoid X receptor).

Main Results:

• MC and Dox inhibited LXR trans-activation in HepG2 cells but not Hep3B cells.
• Exogenous wild-type p53 expression suppressed LXR trans-activation in Hep3B cells.
• MC and Dox reduced ATP binding cassette A1 mRNA and retinoid X receptor protein expression in HepG2 cells.

Conclusions:

• PAH metabolites likely activate p53 via DNA damage, leading to suppression of LXR signaling.
• This p53-mediated pathway represents a direct mechanism by which PAHs interfere with LXR function.
• The findings highlight a novel toxicological pathway impacting lipid metabolism and cellular homeostasis.